“The take-home message here is that for protective health benefits people could not only ideally aim for 10,000 steps a day but also aim to walk faster.”
It might be a stretch to say all Alzheimer’s research is now compromised. But the allegations can prompt us to ask whether the governing bodies of research and drug approvals are truly effective.
Socioeconomic status has been closely linked to a range of health disorders, and dementia is no exception. Studies across multiple countries have shown people with higher socioeconomic status are less likely to develop dementia.
The core of the issue surrounding this drug is simple: Does it actually work? Here’s an explainer on Aduhelm, the new drug to treat Alzheimer’s.
Almost everyone with aphasia struggles when trying to come up with the names of things they know, but can’t find the name for. And because of that, they have trouble using words in sentences. It also affects the ability of those with the condition to read and write.
Why some people with mild cognitive impairment develop dementia while others don’t has long been a mystery. But a recent study has identified several factors that determine whether a person is more or less likely to develop mild cognitive impairment. These findings might give us a clue about who might be more likely to develop dementia.
For nearly two-thirds of women, menopause comes with an undesirable change in memory.
Results reported in JAMA Internal Medicine associate cataract surgery with 30% lower risk of dementia in aging population.
Yet this narrower recommendation raises questions. What does a diagnosis of mild cognitive impairment mean? Is Aduhelm appropriate for all people with mild cognitive impairment, or only some? And who should decide which patients qualify for treatment: dementia specialists or primary care physicians?
Many with long COVID report difficulty with attention and planning — known as ‘brain fog.’
Long before they receive a dementia diagnosis, many people start losing their ability to manage their finances.
Currently, the only approved drugs for Alzheimer’s merely alleviate some of the symptoms and do not stop the disease from progressing.
Tom Seaver, like Robin Williams, had Lewy body dementia, but what is this strange illness? A neurologist explains
NIH study suggests our brains may use search engine strategies to remember words and memories of our past experiences.
Even when people document their choices ― while they still have the ability to do so ― there’s no guarantee those instructions will be honored.